1640 related articles for article (PubMed ID: 26652155)
1. Examining the potential clinical value of curcumin in the prevention and diagnosis of Alzheimer's disease.
Goozee KG; Shah TM; Sohrabi HR; Rainey-Smith SR; Brown B; Verdile G; Martins RN
Br J Nutr; 2016 Feb; 115(3):449-65. PubMed ID: 26652155
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
4. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Tonk S; Kuruva CS; Bhatti JS; Kandimalla R; Vijayan M; Kumar S; Wang R; Pradeepkiran JA; Ogunmokun G; Thamarai K; Quesada K; Boles A; Reddy AP
J Alzheimers Dis; 2018; 61(3):843-866. PubMed ID: 29332042
[TBL] [Abstract][Full Text] [Related]
5. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
[TBL] [Abstract][Full Text] [Related]
6. Solid lipid curcumin particles provide greater anti-amyloid, anti-inflammatory and neuroprotective effects than curcumin in the 5xFAD mouse model of Alzheimer's disease.
Maiti P; Paladugu L; Dunbar GL
BMC Neurosci; 2018 Feb; 19(1):7. PubMed ID: 29471781
[TBL] [Abstract][Full Text] [Related]
7. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review.
da Costa IM; Freire MAM; de Paiva Cavalcanti JRL; de Araújo DP; Norrara B; Moreira Rosa IMM; de Azevedo EP; do Rego ACM; Filho IA; Guzen FP
Curr Neuropharmacol; 2019; 17(5):406-421. PubMed ID: 29338678
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
10. Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research.
Yang H; Zeng F; Luo Y; Zheng C; Ran C; Yang J
Molecules; 2022 Jun; 27(12):. PubMed ID: 35745002
[TBL] [Abstract][Full Text] [Related]
11. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps].
Kuzuhara S
Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and neurodegenerative diseases: a perspective.
Darvesh AS; Carroll RT; Bishayee A; Novotny NA; Geldenhuys WJ; Van der Schyf CJ
Expert Opin Investig Drugs; 2012 Aug; 21(8):1123-40. PubMed ID: 22668065
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and anti-inflammatory effects of curcumin in Alzheimer's disease: Targeting neuroinflammation strategies.
Azzini E; Peña-Corona SI; Hernández-Parra H; Chandran D; Saleena LAK; Sawikr Y; Peluso I; Dhumal S; Kumar M; Leyva-Gómez G; Martorell M; Sharifi-Rad J; Calina D
Phytother Res; 2024 Jun; 38(6):3169-3189. PubMed ID: 38616356
[TBL] [Abstract][Full Text] [Related]
14. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
[TBL] [Abstract][Full Text] [Related]
17. The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.
Pimentel LS; Allard S; Do Carmo S; Weinreb O; Danik M; Hanzel CE; Youdim MB; Cuello AC
J Alzheimers Dis; 2015; 47(2):373-83. PubMed ID: 26401560
[TBL] [Abstract][Full Text] [Related]
18. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease.
Venigalla M; Sonego S; Gyengesi E; Sharman MJ; Münch G
Neurochem Int; 2016 May; 95():63-74. PubMed ID: 26529297
[TBL] [Abstract][Full Text] [Related]
19. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
20. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Hirao K; Shirai N; Sogabe T; Tooyama I
Neurobiol Aging; 2015 Jan; 36(1):201-10. PubMed ID: 25179227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]